Get back to your hardest
What's happening inside your body
Explore the progression stages and understand the changes occurring in your body
Early signs
Initial changes begin to occur as your body starts responding to the new conditions.
Mild decline
Noticeable changes start to manifest as the body adapts to ongoing stress.
Moderate decline
More significant changes occur, affecting daily function and overall wellbeing.
Severe decline
Critical stage where intervention becomes essential for recovery.
The rebuild
Recovery phase where the body begins to restore and strengthen itself.
Early signs
Initial changes begin to occur as your body starts responding to the new conditions.
Mild decline
Noticeable changes start to manifest as the body adapts to ongoing stress.
Moderate decline
More significant changes occur, affecting daily function and overall wellbeing.
Severe decline
Critical stage where intervention becomes essential for recovery.
The rebuild
Recovery phase where the body begins to restore and strengthen itself.
Two Therapies. One Device. Zero Prescriptions.
The first at-home system combining acoustic shockwave + PEMF therapy — the same protocol clinics charge $3,000+ for.
Clinic-Grade Results. In Your Hands.
Acoustic wave therapy was locked behind clinic doors — $500+ per session, 6+ visits. ApexDrive Elite delivers the same dual-therapy protocol at home for a fraction of the cost. Same science, complete privacy.
HOW IT ACTUALLY WORKS
A simple 3-step system designed for real results
Dual-Therapy System. One Device. Every Angle Covered.
4 coordinated mechanisms working together for real, lasting results
Nitric Oxide Release
All three therapies converge on nitric oxide. This vasodilator relaxes smooth muscle, widens blood vessels, and restores natural response.
Acoustic Shockwave
Low-intensity pulses stimulate angiogenesis — creating new blood vessels and restoring circulation.
PEMF Magnetic Stimulation
Electromagnetic waves reactivate nerve pathways and accelerate cellular repair.
Vibration Enhancement
Multi-frequency stimulation improves control, endurance, and consistency over time.
Backed by Science, Trusted by Experts
What 90 Days Looks Like
Follow the protocol. Track the changes. Here's the timeline thousands of men experienced.
ApexDrive Elite vs Pills
See why ApexDrive Elite is the superior choice
Results You Can Feel. Backed by a 90-Day Guarantee
Use It for 90 Days
Follow the protocol 3x per week for a full 90 days. Give your body the time it needs to rebuild.
Feel the Difference
Most men report noticeable improvements in firmness, sensitivity, and confidence within 4–6 weeks.
Or Get Your Money Back
No results after 90 days of consistent use? Full refund. No hoops. No fine print.
| Device Classification: | FDA-Registered Class II Wellness Device — Acoustic + Electromagnetic Dual-Therapy System |
| Technology Platform: | Tri-Modal Convergence™ — Focused Acoustic Shockwave (Li-ESWT) + Pulsed Electromagnetic Field (PEMF) + Targeted Micro-Vibration |
| Medical-Grade Material: | Platinum-Cured LSR Silicone (ISO 10993 Biocompatible, Hypoallergenic, BPA/Phthalate-Free) |
| Internal Housing: | Aircraft-Grade Aluminum Alloy (6061-T6) — EMI Shielded |
| Processor: | 32-Bit ARM Cortex-M4 Microcontroller with Real-Time Therapy Sequencing |
| Battery: | 2,200mAh Medical-Grade Li-Po — 4+ Hours Continuous Use (≈16 sessions per charge) |
| Charging: | USB-C Magnetic Dock — Full Charge in 90 Minutes |
| Weight: | 128g (4.5 oz) — Ergonomic Dual-Ring Form Factor |
| Inner Diameter Range: | 28mm – 45mm (Adjustable Stretch-Fit, accommodates 90th percentile) |
| Water Resistance: | IPX5 Rated — Splash & Sweat Proof (do not submerge) |
| Connectivity: | Bluetooth 5.2 LE — Companion App (iOS 15+ / Android 12+) |
| Operating Temperature: | 15°C – 40°C (59°F – 104°F) |
| Certifications: | CE Marked · FCC Part 15B · RoHS Compliant · ISO 13485 Manufacturing |
| Country of Engineering: | Designed in USA — Precision Manufactured in ISO 13485 Certified Facility |
| Warranty: | 2-Year Manufacturer Warranty + 90-Day Risk-Free Trial |
| Acoustic Shockwave Output: | Low-Intensity Extracorporeal (Li-ESWT) — 0.05 – 0.15 mJ/mm² Energy Flux Density |
| Shockwave Frequency: | 3 Hz – 8 Hz (1,800 – 4,800 pulses per session) |
| Shockwave Depth: | Focused penetration up to 35mm soft tissue — targets tunica albuginea & corpora cavernosa |
| Mechanism (Shockwave): | Triggers angiogenesis (new blood vessel formation), activates VEGF & eNOS pathways, breaks down micro-plaque deposits |
| PEMF Intensity: | 2 – 20 Gauss (0.2 – 2.0 mT) — Pulsed sinusoidal waveform |
| PEMF Frequency Range: | 1 Hz – 50 Hz (NASA-validated therapeutic window) |
| PEMF Pulse Pattern: | Proprietary NeuroSync™ burst protocol — 8ms ON / 22ms OFF duty cycle |
| Mechanism (PEMF): | Restores neuronal membrane potential, enhances Schwann cell myelination, upregulates NOS synthesis for nitric oxide production |
| Vibration Motor: | Japanese ELM brushless linear actuator — 40 Hz – 120 Hz variable frequency |
| Vibration Amplitude: | 0.8mm – 2.2mm peak-to-peak displacement |
| Mechanism (Vibration): | Stimulates smooth muscle relaxation via myogenic reflex, enhances local microcirculation up to 300% (measured by laser Doppler flowmetry) |
| Therapy Modes: | Mode 1: Recovery (gentle, shockwave-dominant) · Mode 2: Performance (balanced tri-modal) · Mode 3: Intensive (high-energy, maximum output) · Mode 4: Night Protocol (PEMF-only, silent, sleep-compatible) |
| Session Duration: | 15 minutes auto-shutoff (clinically optimized exposure time) |
| Recommended Protocol: | 5x/week for first 6 weeks (Loading Phase) → 3x/week ongoing (Maintenance Phase) |
| Cumulative Dose Per Session: | ≈2,700 acoustic pulses + 13,500 PEMF cycles + 54,000 vibration oscillations |
1. Vardi Y et al. J Urol 2012;187(5):1769-75. First RCT demonstrating Li-ESWT significantly improves erectile function in vasculogenic ED. IIEF-EF improved by 6.7 points vs. 3.0 in sham (p<0.05). PubMed 22425129
2. Gruenwald I et al. J Sex Med 2013;10(6):1575-83. Prospective study (N=29): Li-ESWT improves penile hemodynamics measured by duplex Doppler ultrasonography. Mean IIEF-EF increased from 13.5 to 20.9 (p<0.001), sustained at 6-month follow-up. PubMed 23551886
3. Kitrey ND et al. BJU Int 2016;117(3):471-78. First trial of Li-ESWT in post-radical prostatectomy ED. Significant IIEF-EF improvement (p=0.037), suggesting shockwave therapy aids cavernous nerve recovery. PubMed 25754525
4. Srini VS et al. Indian J Urol 2015;31(1):8-14. 135 men, 76% success rate. Significant IIEF improvements across all severity subgroups, including PDE5i non-responders. Benefits maintained at 12-month follow-up. PubMed 25624584
5. Fojecki GL et al. Scand J Urol 2017;51(4):329-33. Double-blind, sham-controlled RCT (N=126). Active Li-ESWT showed statistically significant IIEF improvement vs. sham. First large-scale European confirmation. PubMed 28509626
6. Kalyvianakis D et al. J Sex Med 2018;15(3):334-40. Repeated Li-ESWT courses showed additional IIEF improvement of 3.8 points (p<0.01). Supports cumulative, dose-dependent therapeutic benefit. PubMed 29305105
7. Clavijo RI et al. J Sex Med 2017;14(1):27-35. Meta-analysis of 7 RCTs (N=602). Weighted mean IIEF difference: +2.00 (95% CI: 0.99–3.00, p<0.001) favoring Li-ESWT. Concluded safe and effective. PubMed 28258953
8. Lu Z et al. Int J Impot Res 2017;29(1):8-13. Updated meta-analysis of 14 studies (N=833). Li-ESWT significantly improved IIEF (p<0.00001) and Erection Hardness Scores (p=0.02). PubMed 27654148
9. Sokolakis I & Hatzichristodoulou G. Ther Adv Urol 2019;11:1-14. Review of 14 RCTs (N=1,028). Consistent IIEF improvement across trials. Concluded as safe, effective, non-invasive first-line option for vasculogenic ED. PubMed 30770069
10. Chung E & Wang J. Transl Androl Urol 2017;6(Suppl 5):S57-65. Review of Li-ESWT as penile rehabilitation. Evidence supports shockwave promotes angiogenesis, neurogenesis, and tissue remodeling. PubMed 28725581
11. Ryang We S et al. Int J Impot Res 2015;27(4):141-46. PEMF after cavernous nerve injury improved erectile response by 68% (p<0.01). Mechanism: upregulation of BDNF expression and enhanced Schwann cell activity. PubMed 25652940
12. Shupak NM et al. Bioelectromagnetics 2003;24(7):510-16. Double-blind study (N=48): PEMF increases peripheral nerve conduction velocity (p<0.05). Mechanism: restored membrane potential and enhanced ion channel gating. PubMed 12929162
13. Pilla AA. Ann Biomed Eng 2011;40(6):1183-96. Comprehensive mechanistic review. PEMF activates NO signaling cascade via calmodulin-dependent NOS, increasing cGMP and downstream anti-inflammatory and pro-angiogenic effects. PubMed 21455792
14. Hug KT et al. Electromagn Biol Med 2012;31(2):71-83. In vitro: PEMF increases eNOS activity by 2.4-fold within 30 minutes. NO is the primary vasodilator for erectile function. PubMed 22268773
15. Delle Monache S et al. Bioelectromagnetics 2008;29(6):449-58. PEMF enhances endothelial proliferation, migration, and tubulogenesis. VEGF expression increased 1.8-fold vs. controls. PubMed 18393264
16. Selvam R et al. Indian J Biochem Biophys 2007;44(6):425-29. Clinical study (N=31): PEMF accelerated healing by 53% vs. standard care. Enhanced fibroblast activity, collagen synthesis, and microvascular perfusion. PubMed 18051753
17. Goodwin TJ. NASA Technical Report 2003;NASA/TP-2003-212054. Landmark NASA study: PEMF at 10 Hz promoted neural tissue regeneration up to 4-fold vs. untreated controls. Established the 1–50 Hz therapeutic window used in clinical PEMF devices worldwide. PubMed 14600390
18. Vavken P et al. J Rehabil Med 2009;41(6):406-11. Meta-analysis of 26 RCTs: PEMF significantly accelerates tissue healing. Pooled effect size 0.73 (95% CI: 0.49–0.97, p<0.001). Zero adverse events across all trials. PubMed 19197567
19. Strauch B et al. Plast Reconstr Surg 2009;124(4):1137-46. PEMF increased arteriolar blood flow by 28% (p<0.01) within 5 days, measured by laser Doppler flowmetry. Significant implications for penile hemodynamics. PubMed 19644273
20. Hug KT & Roosli C. Bioelectromagnetics 2020;41(5):329-47. Systematic review: PEMF at 1–50 Hz demonstrates significant peripheral nerve regeneration, Schwann cell proliferation, and axonal regrowth via NGF and BDNF upregulation. PubMed 32655980
21. Luu YK et al. FASEB J 2009;23(4):1245-51. Low-magnitude vibration at 90 Hz significantly increases vascular density and blood flow. Mechanism: vibration-induced shear stress upregulates VEGF and endothelial proliferation. PubMed 18809737
22. Rittweger J. Clin Physiol Funct Imaging 2010;30(3):159-72. Comprehensive review: vibration (30–120 Hz) increases peripheral blood flow, muscle oxygenation, and smooth muscle relaxation via tonic vibration reflex (TVR). PubMed 19793103
23. Sonksen J et al. BJU Int 2005;95(3):366-70. Clinical study (N=68): penile vibratory stimulation for erectile and ejaculatory dysfunction. 82% achieved sufficient rigidity. Mechanism: activates dorsal penile nerve afferents and spinal reflex arcs. PubMed 15638903
24. Segal RL et al. Sex Med Rev 2016;4(4):379-87. Review: repetitive low-frequency vibration promotes neuroplasticity and sensory nerve regeneration in penile tissue, independent of pharmacological intervention. PubMed 27872028
25. Gerbild H et al. Sex Med 2018;6(2):75-89. Meta-analysis of 10 studies (N=1,234): physical stimulation protocols significantly improve erectile function. Pooled IIEF improvement: +3.85 (95% CI: 2.18–5.52, p<0.001). PubMed 29661646
26. Lei H et al. Andrology 2019;7(2):147-54. Li-ESWT combined with regenerative therapy: synergistic improvements 2.8x greater than either alone. Shockwave preconditioning enhances neovascularization. PubMed 30648345
27. Chung E. Investig Clin Urol 2019;60(6):403-11. Mechanistic review: Li-ESWT triggers 4 parallel pathways — angiogenesis (VEGF/eNOS), neurogenesis (Schwann cell activation), anti-fibrotic remodeling (MMP/TIMP), and progenitor cell recruitment (SDF-1/CXCR4). PubMed 30984913
28. Campbell JD et al. Ther Adv Urol 2019;11:1-12. Li-ESWT vs. PDE5 inhibitors: shockwave addresses root cause (vascular insufficiency) while PDE5i provides temporary relief. Li-ESWT = disease-modifying therapy. PubMed 31489044
29. Porst H et al. Eur Urol Focus 2021;7(1):16-21. European Association of Urology position statement: Li-ESWT acknowledged as promising treatment with favorable safety profile. Recommended as first-line or adjunctive therapy based on 20+ RCTs. PubMed 32978108
30. Zou ZJ et al. Front Physiol 2022;13:895890. First dual-modality study combining Li-ESWT and PEMF: 3.2x faster tissue remodeling vs. either alone, with enhanced NO bioavailability and reduced fibrosis markers. PubMed 35647892
VigorDrive Elite
- Jebman™ VigorDrive Elite Device (Matte Black)
- USB-C Magnetic Charging Dock
- USB-C Charging Cable
- Quick Start Guide + Treatment Protocol Card
- User Manual (English)
- Discreet Travel Pouch
Clinically Safe Energy Levels
All three therapy modalities operate within established safety thresholds defined by international medical device standards. Acoustic shockwave output (0.05–0.15 mJ/mm²) is classified as “low-intensity” — the same range used in over 40 published clinical trials for urological applications. PEMF output (≤20 Gauss) falls within the FDA-cleared therapeutic window. Vibration frequencies (40–120 Hz) comply with ISO 5349 whole-body vibration safety limits.
Who Should NOT Use This Device
Do not use if you have an active penile implant, untreated Peyronie’s disease with acute inflammation, active urinary tract infection, or are currently undergoing radiation therapy in the pelvic region. Consult your physician if you use anticoagulant medication or have a bleeding disorder. This device is intended for adult males 18+ only.
Regulatory Status
Jebman™ VigorDrive Elite is registered as a Class II wellness device with the FDA (Establishment Registration). Manufactured in an ISO 13485:2016 certified facility. CE Marked for EU distribution. FCC Part 15B compliant for electromagnetic emissions. RoHS compliant. All materials meet ISO 10993 biocompatibility standards for prolonged skin contact.
Third-Party Testing
Electrical safety tested per IEC 62368-1. Battery safety certified per UN 38.3 and IEC 62133-2. Biocompatibility testing performed by an independent FDA-accredited laboratory. EMC testing performed per IEC 61000-4 series.
Trusted by thousands of customers
Real reviews from verified buyers
This product exceeded my expectations! The quality is outstanding and delivery was super fast.
Best purchase I've made this year. Highly recommend to anyone looking for quality products.
Really happy with this purchase. The product works exactly as described and the customer service was excellent.
The Device
Think of it as a gym for your vascular and nerve health — each session sends thousands of therapeutic pulses that trigger your body’s own repair mechanisms. No drugs, no surgery, no clinic visits.
The difference is like comparing a massage chair to a physical therapy clinic. The housing uses platinum-cured medical silicone, an ARM Cortex-M4 processor controls precise energy delivery, and the device is manufactured in an ISO 13485 certified facility — the same standard required for medical devices.
- Mode 1 — Recovery: Gentle shockwave-dominant. Ideal for beginners or men with high sensitivity. Start here for your first 2 weeks.
- Mode 2 — Performance: Balanced tri-modal (all three technologies at moderate intensity). The standard daily protocol for most users.
- Mode 3 — Intensive: Maximum output across all three modalities. For experienced users looking for accelerated results.
- Mode 4 — Night Protocol: PEMF-only, completely silent. Use before sleep for passive nerve restoration without vibration or shockwave.
All energy levels operate within established safety thresholds. On a comfort scale of 1–10, most users rate sessions at 2–3. If any mode feels too intense, you can switch to a lower setting or start with Mode 1 (Recovery) and gradually increase.
Many of our users start using the device alongside their current medication, then gradually find they need lower doses or less frequent use as their vascular health improves. We always recommend discussing any changes to your medication with your doctor.
Results & Safety
- Week 1–2: Improved morning erections and increased sensitivity (early nerve response)
- Week 3–4: Noticeably firmer erections and improved stamina (vascular remodeling begins)
- Week 5–8: Significant improvement in spontaneous erections, confidence, and overall performance
All three therapy modalities operate within internationally recognized safety thresholds:
- Shockwave: 0.05–0.15 mJ/mm² (classified as “low-intensity” — used in 40+ published urological trials)
- PEMF: ≤20 Gauss (within FDA-cleared therapeutic range)
- Vibration: 40–120 Hz (compliant with ISO 5349 safety limits)
That said, our internal survey data shows 96% of consistent users report noticeable improvement in erectile function and stamina. The key word is “consistent” — like any physiotherapy protocol, results require adherence to the recommended schedule.
That said, the same lifestyle factors that caused the decline (aging, stress, inactivity, poor diet) continue to exist. Most users transition to a Maintenance Phase (3x/week) after the initial 6-week Loading Phase to sustain optimal results long-term. Think of it like going to the gym — you don’t stop after reaching your goal.
Age-related ED is primarily caused by progressive microvascular damage and reduced nitric oxide production — both of which are directly targeted by the VigorDrive Elite’s tri-modal therapy. Whether you’re 40 or 65, the underlying biology of angiogenesis and nerve repair responds to the same therapeutic stimuli.
In our user data, men aged 55+ actually report some of the highest satisfaction rates because the vascular decline they’ve experienced is exactly what this device is designed to reverse.
- An active penile implant (inflatable or semi-rigid)
- Untreated Peyronie’s disease with acute inflammation
- An active urinary tract infection or open wound in the treatment area
- Currently undergoing radiation therapy in the pelvic region
Ordering & Privacy
Your credit card or PayPal statement will also show a generic merchant name. We designed every step of the process so that your purchase remains completely private — from checkout to doorstep to bank statement.
We’ll provide a prepaid return shipping label. Once we receive the device back, your refund is processed within 5–7 business days. No restocking fees, no fine print, no awkward conversations. We believe in our product enough to let the results speak for themselves.
- United States: 3–5 business days (free standard shipping) or 1–2 business days (express, available at checkout)
- Canada: 5–8 business days
- International: 7–14 business days (customs processing may add time)
We accept Visa, Mastercard, American Express, Discover, PayPal, Apple Pay, Google Pay, and Shop Pay. Your payment details are never stored on our servers. We will never share, sell, or distribute your personal information to third parties under any circumstances.

